HTAi and Alira Health Collaborate to Develop a Multi-Stakeholder Value Assessment Framework for Robotic Assisted Surgery & Digital Health

We are proud to coordinate the discussion and consensus of evidence-based guidance on HTA for Robotic Assisted Surgery (RAS) and Digital Health Technologies. This multi-stakeholder Value Assessment Framework will provide guidance on how to overcome challenges in determining the cost-effectiveness of robotic assisted surgery from the perspectives of patients, physicians, and payers

This multi-stakeholder Value Assessment Framework will provide guidance on how to overcome challenges in determining the cost-effectiveness of robotic assisted surgery from the perspectives of patients, physicians, and payers.

The framework, designed in collaboration with the HTAi Medical Device Interest Group, is technology and company agnostic. Key areas of guidance will include:

  • best practices in assessing the value of robotic assisted surgery at both the national and hospital level;
  • how to support the implementation of RAS and Digital Health programs globally;
  • how to ensure the clinician and patient perspectives are included in the quantification of value.

The following areas of consensus will be sought from a panel of leading robotic assisted surgeons, leading health economists and policy makers.

“The guidance will be aimed at HTA agencies globally and will allow them to better assess the value of robotic surgical and digital health systems. We are pleased to be overseeing the operation of such a crucial project and contributing to the development of the consensus document and scientific publication with the recommendations for HTA agencies,” – says Richard Charter, Vice President MedTech Market Access – Europe & Asia Pacific at Alira Health.